DK0631777T3 - Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning - Google Patents

Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning

Info

Publication number
DK0631777T3
DK0631777T3 DK94401461T DK94401461T DK0631777T3 DK 0631777 T3 DK0631777 T3 DK 0631777T3 DK 94401461 T DK94401461 T DK 94401461T DK 94401461 T DK94401461 T DK 94401461T DK 0631777 T3 DK0631777 T3 DK 0631777T3
Authority
DK
Denmark
Prior art keywords
beta
platelet aggregation
inhibit platelet
naphtoquinone derivatives
derivatives
Prior art date
Application number
DK94401461T
Other languages
English (en)
Inventor
Christian Bloy
Bernard Hercelin
Denis Blache
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0631777T3 publication Critical patent/DK0631777T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94401461T 1993-07-02 1994-06-28 Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning DK0631777T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308112A FR2707495B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
DK0631777T3 true DK0631777T3 (da) 2001-03-05

Family

ID=9448828

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94401461T DK0631777T3 (da) 1993-07-02 1994-06-28 Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning

Country Status (13)

Country Link
US (1) US5523322A (da)
EP (1) EP0631777B1 (da)
JP (1) JP3993646B2 (da)
AT (1) ATE197669T1 (da)
CA (1) CA2127215C (da)
DE (1) DE69426317T2 (da)
DK (1) DK0631777T3 (da)
ES (1) ES2154286T3 (da)
FR (1) FR2707495B1 (da)
GR (1) GR3035058T3 (da)
HU (1) HU214058B (da)
PT (1) PT631777E (da)
RU (1) RU2122853C1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (fr) * 1997-05-13 1999-05-04 Jose Remacle Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie.
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR924M (da) * 1959-09-26 1961-11-13

Also Published As

Publication number Publication date
FR2707495A1 (fr) 1995-01-20
CA2127215C (fr) 2004-10-26
ATE197669T1 (de) 2000-12-15
ES2154286T3 (es) 2001-04-01
HUT70508A (en) 1995-10-30
RU94022757A (ru) 1996-09-27
EP0631777A1 (fr) 1995-01-04
DE69426317D1 (de) 2000-12-28
GR3035058T3 (en) 2001-03-30
HU214058B (en) 1997-12-29
FR2707495B1 (fr) 1995-09-01
US5523322A (en) 1996-06-04
EP0631777B1 (fr) 2000-11-22
CA2127215A1 (fr) 1995-01-03
JPH07145128A (ja) 1995-06-06
DE69426317T2 (de) 2001-05-03
JP3993646B2 (ja) 2007-10-17
HU9401978D0 (en) 1994-09-28
PT631777E (pt) 2001-05-31
RU2122853C1 (ru) 1998-12-10

Similar Documents

Publication Publication Date Title
FI940072A (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
DK0633259T3 (da) Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
DE59203976D1 (de) Hydantoinderivate.
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES2126684T3 (es) Utilizacion de derivados de acidos carboxilicos aromaticos para la preparacion de medicamentos.
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
DE69116237D1 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
FI903692A0 (fi) Salter av n5, n10-metylen-5,6,7,8- tetrahydrofolsyra.
ES2154285T3 (es) Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas.
ES2149247T3 (es) Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen.
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
SE8004351L (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar
ES2095492T3 (es) Composicion tintorea a base de derivados de hidroxiindolina.
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.